Literature DB >> 23407295

Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.

Taro Aoba1, Tomoki Ebata, Yukihiro Yokoyama, Tsuyoshi Igami, Gen Sugawara, Yu Takahashi, Yuji Nimura, Masato Nagino.   

Abstract

OBJECTIVE: To analyze lymph node status in resected perihilar cholangiocarcinoma, to clarify which index (ie, location, number, or ratio of involved nodes) is better for staging, and to determine the minimum requirements for node examination.
BACKGROUND: In the TNM classification for perihilar cholangiocarcinoma, the number or ratio of involved nodes is not considered for nodal staging. The minimum requirement for histologic examination of lymph nodes is arbitrary.
METHODS: This study involved 320 patients with perihilar cholangiocarcinoma who underwent resection from January 2000 to December 2009 at Nagoya University Hospital. The relationship between lymph node status and patient survival was retrospectively analyzed.
RESULTS: Total lymph node counts (TLNCs), ie, the number of lymph nodes examined histologically, averaged 12.9 ± 8.3 (range: 1-59). Lymph node metastasis was found in 146 (45.6%) patients and was an independent, powerful prognostic factor. The survival rates were not significantly different between patients with regional node metastasis alone and those with distant node metastasis (19.2% vs 11.5% at 5 years, P = 0.058). The survival for patients with multiple node metastases was significantly worse than that for patients with single metastasis (12.1% vs 27.6% at 5 years, P = 0.002), regardless of the presence or absence of distant lymph node metastasis. The survival for patients with lymph node ratios (LNRs) of 0.2 or less was significantly better than that for patients with LNRs greater than 0.2 (21.4% vs 13.5% at 5 years, P = 0.032). Upon multivariate analysis of the 146 patients with lymph node metastasis, the number of involved nodes (single vs multiple) was identified as an independent prognostic factor (RR of 1.61, P = 0.045), whereas the locations (regional alone vs distant) and ratios (LNR ≤ 0.2 vs LNR > 0.2) of involved nodes were not. When the 148 pN0-R0 patients were divided into 3 groups (ie, those with TLNC ≥ 8, with TLNC = 5, 6, or 7, and with TLNC ≤ 4), survivals were identical between the first and second groups, whereas they were largely different between the former two and the third.
CONCLUSIONS: Lymph node metastasis is a powerful, independent prognostic factor in perihilar cholangiocarcinoma and is better classified based not on location but on the number of involved nodes. To adequately assess nodal status, histologic examination of 5 or more nodes is recommended.

Entities:  

Mesh:

Year:  2013        PMID: 23407295     DOI: 10.1097/SLA.0b013e3182822277

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

1.  Percutaneous biliary drainage is oncologically inferior to endoscopic drainage: a propensity score matching analysis in resectable distal cholangiocarcinoma.

Authors:  Kenichi Komaya; Tomoki Ebata; Yasuyuki Fukami; Eiji Sakamoto; Hideo Miyake; Daisuke Takara; Kenji Wakai; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-11-09       Impact factor: 7.527

2.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

Review 3.  Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.

Authors:  Masato Nagino
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

Review 4.  Assessing resectability in cholangiocarcinoma.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Taira Kinoshita; Yuji Nimura
Journal:  Hepat Oncol       Date:  2013-12-20

5.  Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis.

Authors:  Takashi Mizuno; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Junpei Yamaguchi; Masato Nagino
Journal:  Surg Today       Date:  2016-05-18       Impact factor: 2.549

Review 6.  Radiation therapy for hepatobiliary malignancies.

Authors:  Jonathan W Lischalk; Michael C Repka; Keith Unger
Journal:  J Gastrointest Oncol       Date:  2017-04

7.  Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.

Authors:  B Groot Koerkamp; J K Wiggers; M Gonen; A Doussot; P J Allen; M G H Besselink; L H Blumgart; O R C Busch; M I D'Angelica; R P DeMatteo; D J Gouma; T P Kingham; T M van Gulik; W R Jarnagin
Journal:  Ann Oncol       Date:  2015-06-30       Impact factor: 32.976

8.  Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.

Authors:  Kaitlyn J Kelly; Katerina Dukleska; Deborah Kuk; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; Peter J Allen; William R Jarnagin; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2013-11-09       Impact factor: 5.344

9.  Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Francesca Bertuzzo; Calogero Iacono
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

10.  Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Authors:  Kai Mao; Jieqiong Liu; Jian Sun; Jianlong Zhang; Jie Chen; Timothy M Pawlik; Lisa K Jacobs; Zhiyu Xiao; Jie Wang
Journal:  J Gastroenterol Hepatol       Date:  2016-02       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.